AKI in Multiple Myeloma: Paraproteins, Metabolic Disturbances, and Drug Toxicity
Shah M, Perazella M. AKI in Multiple Myeloma: Paraproteins, Metabolic Disturbances, and Drug Toxicity. Journal Of Onco-Nephrology 2017, 1: 188-197. DOI: 10.5301/jo-n.5000030.Peer-Reviewed Original ResearchAcute kidney injuryMultiple myelomaMyeloma patientsMetabolic disturbancesPresence of AKIDrug-related nephrotoxicityFull renal recoveryProximal tubular injuryTumor lysis syndromeLight chain levelsHigh-cutoff hemodialysisB cell clonesMyeloma managementNephrotoxin exposureRenal recoveryInitial manifestationKidney injuryLysis syndromePrerenal azotemiaFrequent complicationTubular injuryKidney biopsyPlasma exchangeVolume statusExtracorporeal therapy